AlgoDx, a clinical stage medical device software company, has announced obtained the CE mark for NAVOY Sepsis. This medical device is intended to assist medical staff at Intensive Care Units (ICU) to predict sepsis in adult ICU patients.
NAVOY Sepsis is a prediction algorithm based on machine learning that, using only clinical variables routinely collected in Electronic Healthcare Records, predicts the risk of ICU patients developing sepsis in the coming hours.
Andreas Macura, chief product officer, added: “By obtaining the CE mark for NAVOY Sepsis, we hope to support the work of intensive care professionals with its comprehensive machine learning-powered sepsis prediction solution. The real benefits of 24/7 bedside monitoring of sepsis risk are the clinical implications of faster diagnosis and monitoring, given that, in sepsis treatment, the time factor is critical.”